Round Table - Health Invest & Growth 2027

A working lunch at BioLabs Paris on where biotech, techbio, medtech and healthtech money goes in 2027. Three panels, then a lunch reception and a tour of the site. The panels cover dilutive versus non-dilutive financing for post-seed, Series A and Series B companies; scaling organisation and culture as a team moves from R&D into clinical and regulatory work; and whether lab infrastructure can extend a runway. Speaking: Paul Pouyanne (Cathay Innovation), Natacha Brami (SISTAFUND), Anne-Sophie Saint-Martin (New Fund), Estelle Salomon (Speedinvest), Guilhem de Vregille (XAnge), Sarah Pedroza (Fly the Nest) and Alexandre Parlarrieu (ABF Décisions). Hosted by BioLabs and Christophe Tallec, 12:00 to 14:00. Free, registration required. Why go: seven active health investors in one room saying what they will fund next year. Best for life-science founders raising in 2027.